Godavari Drugs Limited (BOM:530317)

India · Delayed Price · Currency is INR

106.01

+7.14 (7.22%)

At close: Sep 4, 2026

Market Cap	798.31M +27.0%
Revenue (ttm)	1.11B +5.4%
Net Income	41.58M +9.7%
EPS	5.03 -0.0%
Shares Out	7.53M
PE Ratio	21.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,819
Open	100.18
Previous Close	98.87
Day's Range	100.10 - 109.40
52-Week Range	69.70 - 135.25
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L... [Read more]

Industry Pharmaceutical Preparations

Founded 1987

Employees 106

Stock Exchange Bombay Stock Exchange

Ticker Symbol 530317

Full Company Profile

Financial Performance

In fiscal year 2026, Godavari Drugs's revenue was 1.07 billion, a decrease of -6.57% compared to the previous year's 1.14 billion. Earnings were 40.89 million, a decrease of -6.64%.

Financial Statements